The Role of IL-6 in Cancer Cell Invasiveness and Metastasis-Overview and Therapeutic Opportunities

被引:98
|
作者
Raskova, Magdalena [1 ,2 ]
Lacina, Lukas [3 ,4 ,5 ,6 ]
Kejik, Zdenek [3 ,4 ,7 ]
Venhauerova, Anna [2 ]
Skalickova, Marketa [2 ]
Kolai, Michal [3 ,8 ]
Jakubek, Milan [3 ,4 ,7 ]
Rosel, Daniel [1 ,2 ]
Smetana, Karel Jr Jr [3 ,4 ,6 ]
Brabek, Jan [1 ,2 ]
机构
[1] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague 12000, Czech Republic
[2] Charles Univ Prague, Fac Sci, BIOCEV, Vestec 25250, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Ctr Tumour Ecol, Prague 12000, Czech Republic
[4] Charles Univ Prague, Fac Med 1, BIOCEV, Vestec 25250, Czech Republic
[5] Charles Univ Prague, Fac Med 1, Inst Anat, Prague 12000, Czech Republic
[6] Charles Univ Prague, Fac Med 1, Dept Dermatovenereol, Prague 12000, Czech Republic
[7] Gen Univ Hosp, Prague 12000, Czech Republic
[8] Czech Acad Sci, Inst Mol Genet, Lab Genom & Bioinformat, Prague 14000, Czech Republic
关键词
IL-6; cancer; metastasis; STAT3; INHIBITOR; PHASE-I; NONPEPTIDE ANTAGONIST; MITOCHONDRIAL STAT3; SIGNALING PATHWAY; TRANSCRIPTION; MADINDOLINE-A; INTERLEUKIN-6; INVASION; GROWTH;
D O I
10.3390/cells11223698
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interleukin 6 (IL-6) belongs to a broad class of cytokines involved in the regulation of various homeostatic and pathological processes. These activities range from regulating embryonic development, wound healing and ageing, inflammation, and immunity, including COVID-19. In this review, we summarise the role of IL-6 signalling pathways in cancer biology, with particular emphasis on cancer cell invasiveness and metastasis formation. Targeting principal components of IL-6 signalling (e.g., IL-6Rs, gp130, STAT3, NF-kappa B) is an intensively studied approach in preclinical cancer research. It is of significant translational potential; numerous studies strongly imply the remarkable potential of IL-6 signalling inhibitors, especially in metastasis suppression.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Role of IL-6 in the invasiveness and prognosis of glioma
    Shan, Yongzhi
    He, Xin
    Song, Wei
    Han, Dong
    Niu, Jianxing
    Wang, Jianzhen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (06): : 9114 - 9120
  • [2] The role and therapeutic targeting of IL-6 in rheumatoid arthritis
    Narazaki, Masashi
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (06) : 535 - 551
  • [3] The role of the interleukin (IL)-6/IL-6 receptor axis in cancer
    Taher, Mustafa Yassin
    Davies, David Marc
    Maher, John
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2018, 46 : 1449 - 1462
  • [4] Role of IL-6 in dendritic cell functions
    Xu, Yu-Dong
    Cheng, Mi
    Shang, Pan-Pan
    Yang, Yong-Qing
    JOURNAL OF LEUKOCYTE BIOLOGY, 2022, 111 (03) : 695 - 709
  • [5] IL-6 variant is associated with metastasis in breast cancer patients
    Abana, Chike O.
    Bingham, Brian S.
    Cho, Ju Hwan
    Graves, Amy J.
    Koyama, Tatsuki
    Pilarski, Robert T.
    Chakravarthy, A. Bapsi
    Xia, Fen
    PLOS ONE, 2017, 12 (07):
  • [6] IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
    Browning, Landon
    Patel, Megha R.
    Horvath, Eli Bring
    Tawara, Ken
    Jorcyk, Cheryl L.
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6685 - 6693
  • [7] The role of IL-6 in TBI and PTSD, a potential therapeutic target?
    Monsour, Molly
    Croci, Davide Marco
    Agazzi, Siviero
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2022, 218
  • [8] Inflammation and prostate cancer: the role of interleukin 6 (IL-6)
    Nguyen, Daniel P.
    Li, Jinyi
    Tewari, Ashutosh K.
    BJU INTERNATIONAL, 2014, 113 (06) : 986 - 992
  • [9] Breast Cancer Brain Metastasis-Overview of Disease State, Treatment Options and Future Perspectives
    Watase, Chikashi
    Shiino, Sho
    Shimoi, Tatsunori
    Noguchi, Emi
    Kaneda, Tomoya
    Yamamoto, Yusuke
    Yonemori, Kan
    Takayama, Shin
    Suto, Akihiko
    CANCERS, 2021, 13 (05) : 1 - 24
  • [10] Cross-talk between EGFR and IL-6 drives oncogenic signaling and offers therapeutic opportunities in cancer
    Ray, Kriti
    Ujvari, Beata
    Ramana, Venkata
    Donald, John
    CYTOKINE & GROWTH FACTOR REVIEWS, 2018, 41 : 18 - 27